Raleigh Capital Management Inc. acquired a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 9,777 shares of the real estate investment trust’s stock, valued at approximately $224,000.
Other large investors have also recently bought and sold shares of the company. Atomi Financial Group Inc. acquired a new position in Healthpeak Properties during the 3rd quarter worth $399,000. Pensionfund Sabic acquired a new position in Healthpeak Properties during the 3rd quarter worth $2,556,000. Mirador Capital Partners LP acquired a new position in Healthpeak Properties during the 3rd quarter worth $737,000. Sarasin & Partners LLP acquired a new position in Healthpeak Properties during the 3rd quarter worth $10,425,000. Finally, GAMMA Investing LLC acquired a new position in Healthpeak Properties during the 3rd quarter worth $605,000. Institutional investors and hedge funds own 93.57% of the company’s stock.
Healthpeak Properties Price Performance
Shares of NYSE DOC opened at $22.43 on Wednesday. The stock has a market capitalization of $15.79 billion, a price-to-earnings ratio of 64.09, a PEG ratio of 2.27 and a beta of 1.14. The business has a 50-day moving average of $22.19 and a 200-day moving average of $20.60. The company has a debt-to-equity ratio of 0.91, a current ratio of 0.70 and a quick ratio of 0.70. Healthpeak Properties, Inc. has a fifty-two week low of $15.24 and a fifty-two week high of $23.14.
Wall Street Analysts Forecast Growth
A number of research firms have recently weighed in on DOC. Citigroup increased their price target on Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. Royal Bank of Canada increased their price target on Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a research note on Tuesday, July 30th. Scotiabank increased their price target on Healthpeak Properties from $23.00 to $24.00 and gave the company a “sector outperform” rating in a research note on Monday, September 9th. StockNews.com downgraded Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Saturday. Finally, Deutsche Bank Aktiengesellschaft raised Healthpeak Properties from a “hold” rating to a “buy” rating and increased their price target for the company from $20.00 to $28.00 in a research note on Monday. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $22.62.
Check Out Our Latest Stock Analysis on DOC
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading
- Five stocks we like better than Healthpeak Properties
- Do ETFs Pay Dividends? What You Need to Know
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- How is Compound Interest Calculated?
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC – Free Report).
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.